Labiana posts revenues of over €39 million in the first half of 2025, up 11.7% year-on-year
Labiana posts strong H1 2025 results with €7.4M adjusted EBITDA, up 12.8%, driven by growth in animal and human health divisions. MADRID, MADRID, SPAIN, October 31, 2025 /EINPresswire.com/ -- Labiana, the Spanish pharmaceutical group dedicated …